Funding opportunities

Below is a list of funding opportunities that may be of interest to the Ontario cancer research community.

If you wish to list a funding opportunity here, contact christopher.needles@oicr.on.ca.


Jump to: Health Services Research  | OMPRN Funding | OCTANE Request for Proposal (RFP)


Health Services Research

Background

In collaboration with Cancer Care Ontario, the Ontario Institute for Cancer Research (OICR) is excited to announce a new funding opportunity to support health services research projects that will provide the knowledge needed to optimize the delivery of cancer services today and to ensure appropriate dissemination of health service innovations and well-evaluated technologies.

Available funding

Up to $150,000 per year for a maximum of two years for projects related to one of the following priority areas. Projects that address hard-to-treat cancers and/or have a clear trajectory to intervention studies are preferred.

      1. Data infrastructure, integration and mobilization studies (e.g., data linkage, quality, access, governance, and policy, including privacy and ethics considerations);
      2. Use of Real-World Evidence to advance innovations in health care and health technology assessments;
      3. Research addressing health care system adoption of accepted best practices related to precision medicine;
      4. Use of artificial intelligence and digital health tools by health care systems and their impact on access to care, models of care, quality and cost of care, and patient outcomes;
      5. Knowledge translation and dissemination projects; and
      6. Population health studies (e.g., prevention and screening).

Eligibility

Individuals based in, or formally affiliated with, an Ontario Host Institution, such as a university, research institute, research hospital, or not-for-profit organization with an explicit research mandate.

Timeline

Activity Date
Registration deadline August 17, 2018 by 5:00 p.m. EDT
Response to registrants August 24, 2018
Letter of Intent (LOI) deadline September 14, 2018 by 5 p.m. EDT
Response to LOI applicants End of October 2018
Full application deadline December 3, 2018 by 5 p.m. EST
Notification of results End of April 2019
Funding to begin April 1, 2019*
Funding term end date (maximum) March 31, 2021

*Funding start date will be retroactive to April 1, 2019 for successful projects.

Questions

Contact OICR’s Scientific Secretariat department: scientificsecretariat@oicr.on.ca

This opportunity is funded in collaboration with Cancer Care Ontario.


OMPRN Funding

Cancer Pathology Translational Research Grants

Ontario Molecular Pathology Research Network’s (OMPRN) vision is to create a province-wide network of pathologists collaborating to carry out high-quality cancer research with a clear potential for clinical utility. The OMPRN Steering Committee has developed objectives under the three broad themes of (i) Awareness & Outreach, (ii) Education, and (iii) Pathology-led Research. The Cancer Pathology Translational Research Grant (CPTRG) Streams address the latter objective by supporting projects in which the primary drivers are pathologists and the primary focus is on pathology cancer research.

Cancer Pathology Translational Research Grants will build the capacity of Ontario pathologists to undertake transdisciplinary research projects that advance the field of cancer diagnostic, prognostic or predictive testing and provide learning opportunities for pathology residents or early-career pathologists.

See more details

Cancer Pathology Translational Research Grants

Ontario Molecular Pathology Research Network’s (OMPRN) vision is to create a province-wide network of pathologists collaborating to carry out high-quality cancer research with a clear potential for clinical utility. The OMPRN Steering Committee has developed objectives under the three broad themes of (i) Awareness & Outreach, (ii) Education, and (iii) Pathology-led Research. The Cancer Pathology Translational Research Grant (CPTRG) Streams address the latter objective by supporting projects in which the primary drivers are pathologists and the primary focus is on pathology cancer research.

Cancer Pathology Translational Research Grants will build the capacity of Ontario pathologists to undertake transdisciplinary research projects that advance the field of cancer diagnostic, prognostic or predictive testing and provide learning opportunities for pathology residents or early-career pathologists.

See more details


OCTANE Request for Proposal (RFP)

The Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) Steering Committee is seeking project proposals that will leverage the use of banked OCTANE tumour tissue and blood samples in hypothesis-driven research studies of diagnostic utility, clinical impact, or unmet need in cancer care. OCTANE is an OICR-supported initiative that offers targeted next-generation sequencing of tumour DNA through Ontario Laboratory Accreditation-certified clinical testing laboratories, while concurrently establishing a large and ever-expanding centralized biorepository of tumour and blood samples for future research studies. There are currently 1337 OCTANE cases with tissue (DNA, RNA, and/or unstained slides) and 2055 cases with blood (buffy coat, buffy coat DNA, plasma, plasma DNA) available for analysis under proposed research projects.

For more information regarding this RFP, please see the attached document. To submit a project proposal, please complete the OCTANE Project Proposal Form and send the completed form to Celeste Yu (celeste.yu@uhn.ca) by May 15, 2019.

If you have any questions regarding this RFP, please contact Celeste Yu (celeste.yu@uhn.ca) or the OCTANE Principal Investigator, Dr. Philippe Bedard (philippe.bedard@uhn.ca).